- Home
- SPPL vs POAI Comparison
SPPL vs POAI Comparison
Compare SPPL & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPPL
- POAI
- Stock Information
- Founded
- SPPL 2016
- POAI 2002
- Country
- SPPL Singapore
- POAI United States
- Employees
- SPPL N/A
- POAI N/A
- Industry
- SPPL
- POAI Industrial Specialties
- Sector
- SPPL
- POAI Health Care
- Exchange
- SPPL Nasdaq
- POAI Nasdaq
- Market Cap
- SPPL 10.4M
- POAI 8.9M
- IPO Year
- SPPL 2023
- POAI N/A
- Fundamental
- Price
- SPPL $2.78
- POAI $0.89
- Analyst Decision
- SPPL
- POAI Hold
- Analyst Count
- SPPL 0
- POAI 1
- Target Price
- SPPL N/A
- POAI N/A
- AVG Volume (30 Days)
- SPPL 9.1K
- POAI 93.9K
- Earning Date
- SPPL 01-01-0001
- POAI 08-12-2025
- Dividend Yield
- SPPL N/A
- POAI N/A
- EPS Growth
- SPPL N/A
- POAI N/A
- EPS
- SPPL N/A
- POAI N/A
- Revenue
- SPPL $2,764,846.00
- POAI $1,729,269.00
- Revenue This Year
- SPPL N/A
- POAI $486.27
- Revenue Next Year
- SPPL N/A
- POAI $65.50
- P/E Ratio
- SPPL N/A
- POAI N/A
- Revenue Growth
- SPPL N/A
- POAI 24.17
- 52 Week Low
- SPPL $2.02
- POAI $0.55
- 52 Week High
- SPPL $16.80
- POAI $3.06
- Technical
- Relative Strength Index (RSI)
- SPPL 45.02
- POAI 38.00
- Support Level
- SPPL $2.57
- POAI $0.85
- Resistance Level
- SPPL $2.86
- POAI $0.91
- Average True Range (ATR)
- SPPL 0.19
- POAI 0.06
- MACD
- SPPL 0.02
- POAI -0.00
- Stochastic Oscillator
- SPPL 38.26
- POAI 4.12
About SPPL SIMPPLE LTD.
Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.